XM does not provide services to residents of the United States of America.

Beiersdorf posts 9-month sales growth, flags China weakness



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Beiersdorf posts 9-month sales growth, flags China weakness</title></head><body>

Adds CEO quote in paragraph 3, context in 4, China details in 5, outlook in 9

By Elizaveta Gladun and Linda Pasquini

Oct 24 (Reuters) -Nivea maker Beiersdorf BEIG.DE on Thursday reported an increase in group sales for the first nine months of 2024, but flagged persisting challenges in the Chinese luxury market.

Nine-month sales rose 6.5% organically to 7.55 billion euros ($8.15 billion) from 7.26 billion euros a year earlier, helped by a rebound in North America and growth in its skin care segment.

"The luxury market however, especially in China, continues to be challenging," CEO Vincent Warnery said in a statement.

A slowdown in Chinese consumer demand amid a weak economy has hit the luxury sector, which is reliant on discretionary spending, weighing on quarterly sales at French peer L'Oreal OREP.PA and industry bellwether LVMH, LVMH.PA among others.

Sales in Beiersdorf's luxury brand La Prairie dropped by 7.3% in organic terms in the first three quarters, driven by the continued weakness of the Greater China region, and its negative impact on the travel retail market, the company said.

Meanwhile the company's core brands have remained resilient. Sales in the overall consumer segment rose 7.3% to 6.3 billion euros in the first nine months of 2024.

This was helped by double-digit growth rates for the skincare brands Eucerin and Aquaphor in North America and strong Nivea sales in emerging markets in the third quarter, the company said.

Beiersdorf still expects organic sales growth of 6-8% in 2024 and margin on earnings before interest and taxes (EBIT), excluding special factors, to be slightly above the previous year's level.

($1 = 0.9267 euros)



Reporting by Elizaveta Gladun, Linda Pasquini, and Matthias Inverardi; editing by Rachel More and Lincoln Feast.

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.